| __timestamp | Geron Corporation | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 8901000 | 4167274 |
| Thursday, January 1, 2015 | 9574000 | 5247851 |
| Friday, January 1, 2016 | 14695000 | 4925118 |
| Sunday, January 1, 2017 | 8437000 | 14930297 |
| Monday, January 1, 2018 | 12723000 | 25371768 |
| Tuesday, January 1, 2019 | 51272000 | 23921274 |
| Wednesday, January 1, 2020 | 50052000 | 25338236 |
| Friday, January 1, 2021 | 783000 | 20182966 |
| Saturday, January 1, 2022 | 868000 | 17562000 |
| Sunday, January 1, 2023 | 123740000 | 25212000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, understanding the financial health of companies is crucial. This analysis compares the cost of revenue for Pharming Group N.V. and Geron Corporation from 2014 to 2023. Over this period, Pharming Group N.V. consistently maintained a more stable cost structure, with costs peaking in 2018 at approximately 25 million, a 500% increase from 2014. In contrast, Geron Corporation experienced significant fluctuations, with a dramatic surge in 2023, reaching nearly 124 million, a staggering 1,300% increase from its 2014 figures.
This comparison highlights the diverse financial strategies within the biotech sector, offering valuable insights for investors and industry analysts.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs Pharming Group N.V.
Analyzing Cost of Revenue: Vertex Pharmaceuticals Incorporated and Pharming Group N.V.
Takeda Pharmaceutical Company Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
United Therapeutics Corporation vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Pharming Group N.V.
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Geron Corporation
Walgreens Boots Alliance, Inc. vs Geron Corporation: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Agios Pharmaceuticals, Inc.
Cost Insights: Breaking Down Pharming Group N.V. and Dyne Therapeutics, Inc.'s Expenses
Pharming Group N.V. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Comparison: Geron Corporation vs Travere Therapeutics, Inc.